Picture [iito] Made Without Love 650x80px
Document › Details

Curetis N.V.. (4/27/18). "Press Release: Curetis to Raise EUR 4.1 Million in Equity Offering with Access to Additional USD 10 million in Equity Over 36 Months [Not for United States, Australia, Canada, Japan, or any other jurisdiction where unlawful]". A

Region Region United States (USA)
Organisations Organisation Curetis GmbH
  Group OpGen (Group)
  Organisation 2 Global Corporate Finance (GCF) (US)
Products Product Unyvero molecular diagnostics platform
  Product 2 investment banking
Index terms Index term Curetis–SEVERAL: investment, 201804 capital increase €4.1m offering of 854k new ordinary shares at €4.8/share to qualified EU + US investors
  Index term 2 Curetis–Global Corporate Finance: investment, 201804–202103 equity facility $10m solely at Curetis request up to 36 months at pre-agreed floor pricing
Persons Person Schacht, Oliver (Curetis 201012– CEO before Epigenomics CFO)
  Person 2 Weß, Ludger (akampion before 2001–2006 BioCentury Senior Editor before Financial Times Deutschland)

Record changed: 2018-05-01


Picture [iito] Made Without Love 650x80px

More documents for OpGen (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Hotspot for Startups 650x80px

» top